Skip to main content

and
  1. Article

    Open Access

    Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa

    Pseudomonas aeruginosa colonises the upper airway of cystic fibrosis (CF) patients, providing a reservoir of host-adapted genotypes that subsequently establish chronic lung infection. We previously experimentally...

    Laura Bricio-Moreno, Victoria H. Sheridan, Ian Goodhead in Nature Communications (2018)

  2. No Access

    Protocol

    EpiSweep: Computationally Driven Reengineering of Therapeutic Proteins to Reduce Immunogenicity While Maintaining Function

    Therapeutic proteins are yielding ever more advanced and efficacious new drugs, but the biological origins of these highly effective therapeutics render them subject to immune surveillance within the patient’s...

    Yoonjoo Choi, Deeptak Verma, Karl E. Griswold in Computational Protein Design (2017)

  3. No Access

    Article

    Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity

    Staphylococcus aureus is a dangerous bacterial pathogen whose clinical impact has been amplified by the emergence and rapid spread of antibiotic resistance. In the search for more effecti...

    Daniel C. Osipovitch, Sophie Therrien in Applied Microbiology and Biotechnology (2015)

  4. No Access

    Article

    Computationally driven deletion of broadly distributed T cell epitopes in a biotherapeutic candidate

    Biotherapeutics are subject to immune surveillance within the body, and anti-biotherapeutic immune responses can compromise drug efficacy and patient safety. Initial development of targeted antidrug immune me...

    Regina S. Salvat, Andrew S. Parker in Cellular and Molecular Life Sciences (2014)

  5. No Access

    Chapter and Conference Paper

    Structure-Guided Deimmunization of Therapeutic Proteins

    Therapeutic proteins continue to yield revolutionary new treatments for a growing spectrum of human disease, but the development of these powerful drugs requires solving a unique set of challenges. For instanc...

    Andrew S. Parker, Karl E. Griswold in Research in Computational Molecular Biology (2012)

  6. No Access

    Chapter and Conference Paper

    Optimization of Combinatorial Mutagenesis

    Protein engineering by combinatorial site-directed mutagenesis evaluates a portion of the sequence space near a target protein, seeking variants with improved properties (stability, activity, immunogenicity, e...

    Andrew S. Parker, Karl E. Griswold in Research in Computational Molecular Biology (2011)

  7. Article

    Open Access

    Optimization algorithms for functional deimmunization of therapeutic proteins

    To develop protein therapeutics from exogenous sources, it is necessary to mitigate the risks of eliciting an anti-biotherapeutic immune response. A key aspect of the response is the recognition and surface di...

    Andrew S Parker, Wei Zheng, Karl E Griswold, Chris Bailey-Kellogg in BMC Bioinformatics (2010)

  8. Article

    Open Access

    Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid libraries

    In addition to providing the molecular machinery for transcription and translation, recombinant microbial expression hosts maintain the critical genotype-phenotype link that is essential for high throughput sc...

    Thomas C Scanlon, Elizabeth C Gray, Karl E Griswold in BMC Biotechnology (2009)

  9. No Access

    Chapter and Conference Paper

    Protein Fragment Swap**: A Method for Asymmetric, Selective Site-Directed Recombination

    This paper presents a new approach to site-directed recombination, swap** combinations of selected discontiguous fragments from a source protein in place of corresponding fragments of a target protein. By be...

    Wei Zheng, Karl E. Griswold in Research in Computational Molecular Biology (2009)

  10. No Access

    Protocol

    pH Sensing Agar Plate Assays for Esterolytic Enzyme Activity

    Lipases and esterases are some of the most extensively used enzymes for biotransformations (13). This is in part due to their widely applicable chemistry, often exceptional regio- and stereo-selectivity, lack of...

    Karl E. Griswold in Directed Enzyme Evolution (2003)